Subsection

Kane Biotech Announces Closing of Fully Subscribed Private Placement Offering and Amendments to its Credit Facility

Retrieved on: 
Tuesday, September 12, 2023
Exercise, Minority, Private placement, Subsection, TSX Venture Exchange, MI, United States Department of Defense, Defense, Surety, Unit, Person, Sale, Pivot, KNE, Primary Dealer Credit Facility, Credit, Multilateral, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, News, Food, Security (finance), Warrant

WINNIPEG, Manitoba, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company”, “Kane” or “Kane Biotech”) announces that on September 11, 2023 it has fully subscribed and closed its previously announced non-brokered private placement offering (the “Offering”) of units of the Company (“Units”). Kane issued 6,250,000 Units at a price of $0.08 per Unit for aggregate gross proceeds of $500,000. Each Unit is comprised of one common share of the Company (a “Share”) and one-half of one Share purchase warrant (each whole warrant, a “Warrant”). Each full Warrant entitles the holder thereof to purchase one additional Share of the Company for a period of 18 months at an exercise price of $0.10 per Share.

Key Points: 
  • Not for distribution to U.S. news wire services or dissemination in the United States
    WINNIPEG, Manitoba, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company”, “Kane” or “Kane Biotech”) announces that on September 11, 2023 it has fully subscribed and closed its previously announced non-brokered private placement offering (the “Offering”) of units of the Company (“Units”).
  • Kane issued 6,250,000 Units at a price of $0.08 per Unit for aggregate gross proceeds of $500,000.
  • Under the terms of the Amended Credit Facility, Pivot and the third party guarantor of $1,000,000 of the Amended Credit Facility (the “Guarantor”), each received 2,500,000 compensation warrants (“Compensation Warrants”).
  • The closing of the Amended Credit Facility remains subject to the final approval of the TSX Venture Exchange.

OliX Pharmaceuticals Announces Positive Results from a Phase 2a Trial of OLX10010 for Hypertrophic Scar Treatment

Retrieved on: 
Friday, April 28, 2023
Health, Surgery, Other Health, Other Science, Science, Pharmaceutical, Biotechnology, CTGF, Subsection, University, Therapy, Baptist Hospital, Multimedia, Patient, Fibrosis, KOSDAQ, Standard of care, RNA interference, Safety, Pharmaceutical industry, Dermatology, Medicine

OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, today announced positive headline results of a phase 2a trial in the treatment of hypertrophic scars which met the primary observer-based endpoint at week 24 as evaluated by the Patient and Observer Scar Assessment Scale (POSAS).

Key Points: 
  • OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, today announced positive headline results of a phase 2a trial in the treatment of hypertrophic scars which met the primary observer-based endpoint at week 24 as evaluated by the Patient and Observer Scar Assessment Scale (POSAS).
  • The trial ascertained the effects of intradermal OLX10010, initiated 2 weeks after surgery and administered biweekly over 12 weeks versus placebo in adult patients with hypertrophic scars.
  • This trial uses a randomized, double-blind, placebo-controlled, multi-center, intrasubject trial design and continues until week 48 after surgery.
  • We are excited about the initial results from this trial, supporting the development of OLX10010 as backbone treatment for patients with hypertrophic scars, when used alone and in combination with standard of care and future novel treatments.”

Delta 9 Completes Private Placement of Common Share

Retrieved on: 
Friday, September 9, 2022
Indian stock exchange, Multilateral, Toronto Stock Exchange, OTCQX, Company, Offering, GLOBE, News, Delta, Forward-looking statement, Foot, TSX, Minority, Subsection, DN, SEDAR, Cannabis, Risk, MI, Drug, Audit

WINNIPEG, Manitoba, Sept. 09, 2022 (GLOBE NEWSWIRE) -- DELTA 9 CANNABIS INC. (TSX: DN) (OTCQX: DLTNF) ("Delta 9" or the "Company"), announces that it has completed a private placement of 1,650,000 common shares of the Company (Common Shares), for a deemed price of $0.1250 per Common Share, to various subscribers (the Offering).

Key Points: 
  • WINNIPEG, Manitoba, Sept. 09, 2022 (GLOBE NEWSWIRE) -- DELTA 9 CANNABIS INC. (TSX: DN) (OTCQX: DLTNF) ("Delta 9" or the "Company"), announces that it has completed a private placement of 1,650,000 common shares of the Company (Common Shares), for a deemed price of $0.1250 per Common Share, to various subscribers (the Offering).
  • Delta 9's wholly-owned subsidiary, Delta 9 Bio-Tech Inc., is a licensed producer of medical and recreational cannabis and operates an 80,000 square foot production facility inWinnipeg, Manitoba, Canada.
  • Delta 9 owns and operates a chain of retail stores under the Delta 9 Cannabis Store brand.
  • Delta 9's shares trade on the Toronto Stock Exchange under the symbol "DN" and on the OTCQX under the symbol "DLTNF".

ANDERSON, MCPHARLIN & CONNERS' VANESSA WIDENER NAMED AMONG TOP 100 LAWYERS IN LOS ANGELES

Retrieved on: 
Thursday, May 26, 2022
Subsection, Fraud, Real estate, Lawyer, Los Angeles County Bar Association, Lawsuit, Conners, Tort Trial & Insurance Practice Section, Ownership, Trust, Widener, Title insurance, Journal, American Bar Association, Daily Journal Corporation, McPharlin, Member, Probate, Property management

View original content:https://www.prnewswire.com/news-releases/anderson-mcpharlin--conners-van...

Key Points: 
  • LOS ANGELES, May 26, 2022 /PRNewswire/ --Los Angeles based law firm Anderson, McPharlin & Conners LLP announced today that Managing Partner Vanessa H. Widener has been recognized as a "Top 100 Lawyer" by the Los Angeles Business Journal.
  • According to the journal's publisher Josh Schimmels, the 100 lawyers selected "have demonstrated exceptional legal skill and achievements across the full spectrum of responsibility, exemplary leadership and contributions to the Los Angeles community at large."
  • Widener, one of the firm's managing partners, is a civil litigator based out of the firm's Los Angeles Office.
  • On a local level, Widener is also an active member of the Los Angeles County Bar Association, Title Insurance Subsection of the Real Property Section.

Kane Biotech Announces Closing of Private Placement

Retrieved on: 
Tuesday, May 17, 2022
Company, Subsection, Multilateral, Indian stock exchange, News, TSX Venture Exchange, Biofilm, Minority, Research, Intellectual property, Sale, Person, MI, GLOBE, Security (finance)

WINNIPEG, Manitoba, May 17, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company” or “Kane Biotech”) is pleased to announce that it has closed its non-brokered private placement offering (the “Offering”) announced previously on March 15, 2022, and has issued 10,000,000 common shares of the Company ("Common Shares") at a price of $0.10 per Common Share to raise gross proceeds of $1,000,000.

Key Points: 
  • President and Chief Executive Officer, Marc Edwards, participated for a total of $310,000 (3,100,000 Common Shares) in the Offering (the Insider Subscription).
  • The closing of the Offering remains subject to the final approval of the TSX Venture Exchange.
  • Kane Biotech is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms.
  • StrixNB, DispersinB, Aledex, bluestem, bluestem, silkstem, goldstem, coactiv+, coactiv+, DermaKB and DermaKB Biofilm are trademarks of Kane Biotech.

Peak Fintech Completes Acquisition of Analytics and AI Company Cubeler Inc.

Retrieved on: 
Friday, October 1, 2021
News, Minority, Artificial intelligence, Subsection, Multilateral, CV, Acquisition, Related party transaction, CSE, MI, SME, Hub, Marketing, PKK, Company, Technology, Ecosystem, Industry, Bank

MONTREAL, Oct. 1, 2021 /PRNewswire/ - Peak Fintech Group Inc. (CSE: PKK) ("Peak" or the "Company"), an innovative Fintech service provider and manager of the Cubeler Business Hub, today announced that it has officially acquired analytics and AI company Cubeler Inc. ("Cubeler").

Key Points: 
  • MONTREAL, Oct. 1, 2021 /PRNewswire/ - Peak Fintech Group Inc. (CSE: PKK) ("Peak" or the "Company"), an innovative Fintech service provider and manager of the Cubeler Business Hub, today announced that it has officially acquired analytics and AI company Cubeler Inc. ("Cubeler").
  • Peak first announced its intension to acquire Cubeler on August 16, 2021 pending satisfactory due diligence, a pricing report on Cubeler and a fairness opinion from an independent third party on the proposed acquisition.
  • Peak is pleased to announce that it has now acquired 100% of Cubeler's issued and outstanding shares form Cubeler's shareholders in exchange for $1,000,000 in cash and 11,133,012 common shares of Peak (the "Acquisition").
  • About Peak Fintech Group Inc.:
    Peak Fintech Group Inc. is the parent company of a group of innovative financial technology (Fintech) subsidiaries operating primarily in the commercial lending industry.

Peak Fintech Signs Agreement to Acquire Analytics and AI Company Cubeler Inc., Paving the Way for Its North American Expansion

Retrieved on: 
Monday, August 16, 2021
PEI, PKK, CSE, Ecosystem, MI, Element, Company, Hub, Subsection, Related party transaction, Acquisition, Technology, Multilateral, AI, Artificial intelligence, Minority, German American Business Association, Industry, Airline, Bank

Cubeler ( https://www.cubeler.com/ ) is an analytics and AI company located in Montreal.

Key Points: 
  • Cubeler ( https://www.cubeler.com/ ) is an analytics and AI company located in Montreal.
  • The company developed and owns the world-wide commercial rights to the technology at the core of Peak's Business Hub.
  • Cubeler leverages the data collected throughout its ecosystem to develop and commercialize a series of analytics and AI-based applications.
  • About Peak Fintech Group Inc.:
    Peak Fintech Group Inc. is the parent company of a group of innovative financial technology (Fintech) subsidiaries operating primarily in the commercial lending industry.